Alzai Health Corp. ALZI.V
TSX
| 07/31/2026 | 04/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -100.00% | |||
| Cost of Revenue | 13.39% | 50.29% | |||
| Gross Profit | 15.81% | -109.98% | |||
| SG&A Expenses | 104.17% | -71.13% | |||
| Depreciation & Amortization | 2.78% | 16.13% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 42.17% | -54.72% | |||
| Operating Income | -36.04% | 53.89% | |||
| Income Before Tax | -33.33% | 49.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -33.33% | 49.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.33% | 49.36% | |||
| EBIT | -36.04% | 53.89% | |||
| EBITDA | -36.06% | 53.96% | |||
| EPS Basic | -19.00% | 49.75% | |||
| Normalized Basic EPS | -20.97% | 50.00% | |||
| EPS Diluted | -19.00% | 49.75% | |||
| Normalized Diluted EPS | -20.97% | 50.00% | |||
| Average Basic Shares Outstanding | 12.03% | 0.43% | |||
| Average Diluted Shares Outstanding | 12.03% | 0.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||